Carvolix is a French medical technologies company, commercial and clinical stage, founded by Truffle Capital, that aims to become a global leader in the treatment of structural heart diseases and strokes, world's leading causes of mortality and disability. 

Carvolix develops novel AI and imaging driven mini-robots that make complex procedures doble by interventional cardiologists, as well as biomimetics heart valves.

Carvolix

Christophe de VREGILLE

This department focuses on the design, development, and validation of mechanical systems and components.

Mechanical Engineering

This department focuses on innovating and developing new hardware and embedded software solutions.

Research and Development

This department focuses on the design, development, and testing of mechanical and mechatronic systems.

Engineering Department

This department focuses on strategizing and overseeing marketing initiatives and program management to drive organizational goals.

Marketing and Programs

This department manages and oversees clinical trials and ensures the quality and integrity of operations within healthcare and research settings.

Clinical Operations

This department oversees financial strategies, governance, and compliance within the organization.

Carvolix

Org chart

Teams

Mechanical Engineering

Research and Development

Engineering Department

Marketing and Programs

Clinical Operations

Finance and Governance

Offices

Carvolix

Org chart

Teams

Mechanical Engineering

Research and Development

Engineering Department

Marketing and Programs

Clinical Operations

Finance and Governance

Offices

Related companies